Free Trial

Avenue Therapeutics (ATXI) SEC Filings & 10K Form

Avenue Therapeutics logo
$2.01 +0.04 (+2.03%)
(As of 11/20/2024 ET)

Recent Avenue Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
2:22 PM
ARMISTICE CAPITAL, LLC (Filed by)
Avenue Therapeutics (Subject)
Form SC 13G
11/07/2024
6:12 PM
Avenue Therapeutics (Issuer)
KRANZLER JAY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:18 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:53 PM
Avenue Therapeutics (Issuer)
Charles Faith L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:53 PM
Avenue Therapeutics (Issuer)
Jin David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:54 PM
Avenue Therapeutics (Issuer)
KRANZLER JAY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:55 PM
Avenue Therapeutics (Issuer)
MacLean Alexandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:55 PM
Avenue Therapeutics (Issuer)
Oltmans Curtis Gale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:57 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:59 PM
Avenue Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
3:16 PM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/26/2024
3:52 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
7:30 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
8:01 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2024
11:15 PM
Avenue Therapeutics (Filer)
Form EFFECT
03/29/2024
1:41 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
6:15 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
3:31 PM
Avenue Therapeutics (Filer)
Form PRE 14C
02/23/2024
3:17 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
11:15 PM
Avenue Therapeutics (Filer)
Form EFFECT
01/29/2024
7:00 AM
Avenue Therapeutics (Filer)
Form DEF 14C
01/17/2024
4:05 PM
Avenue Therapeutics (Filer)
Form PRE 14C
01/12/2024
5:01 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
4:28 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
2:45 PM
Avenue Therapeutics (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
11/28/2023
3:01 PM
Avenue Therapeutics (Issuer)
Davidow Robert L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/24/2023
12:19 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ATXI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners